510(k) device
Leksell GammaPlan (LGP)
Elekta Solutions AB · System, Radiation Therapy, Radionuclide (IWB, Class II) · First FDA decision Feb 8, 2024, newest Feb 8, 2024Brain tumorsCancer radiation therapy
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Leksell GammaPlan"
MAUDE reports
8
Brand "Leksell GammaPlan", since 2015
PubMed studies
96
Mentioning "Leksell GammaPlan"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Leksell GammaPlan (LGP)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Leksell GammaPlan (LGP)510(k)
K232854 · Decided Feb 8, 2024 · 146 days after receipt
Device type: System, Radiation Therapy, Radionuclide (IWB) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Hyperbaric Oxygen Therapy for Chronic Radiation Induced Proctitis and EnteritisNational analysisReview closedCAG-00060R2Updated Nov 18, 2026
- Stereotactic Radiation Therapy: Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT)Local determinationIn effectL35076Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40168Wellpoint FederalUpdated Jul 14, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40179CGS Administrators, LLCUpdated Apr 17, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40193WPS Insurance CorporationUpdated Mar 12, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40189Palmetto GBAUpdated Mar 11, 2026
- Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)Local determinationIn effectL40176Noridian Healthcare Solutions, LLCUpdated Mar 10, 2026
- Intraoperative Radiation TherapyLocal determinationIn effectL37779Palmetto GBAUpdated Jul 23, 2021
Clinical trials
Device studies on ClinicalTrials.gov that name "Leksell GammaPlan", any status and sponsor, newest update first.
No registered device study names "Leksell GammaPlan".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Leksell GammaPlan", and for the whole product code for context.
This brand
8 reports: 5 malfunction, 3 injury, 0 death
Whole product code IWB
27 reports: 20 malfunction, 6 injury, 1 death
Newest reports for this brand
- LEKSELL GAMMAPLANMalfunction
3015232217-2025-00063 · Received Dec 23, 2025
Device type: System, Planning, Radiation Therapy Treatment (MUJ)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Unintended Radiation Exposure
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Leksell GammaPlan"[tiab]. The summary above synthesizes these.
- Dosimetric evaluation of the Leksell GammaPlanࡊ Convolution dose calculation algorithm.
Logothetis A, Pantelis E, Zoros E, et al. · Phys Med Biol · 2020Research Support, Non-U.S. Gov't
- Efficacy of 3D evaluation of unruptured paraclinoid aneurysms within Leksell GammaPlan® for determination of their intradural localization.
Ottomo D, Hayashi M, Kawashima A, et al. · J Clin Neurosci · 2023
- A practical strategy for incorporating the convolution algorithm in Leksell GammaPlan for routine treatment planningߤ.
Watanabe Y, Mathew D, Natanasabapathi G · J Radiosurg SBRT · 2022
- Radiosurgery for radiosurgery-induced cavernous malformation.
Park YS, Kim SH, Chang JH, et al. · World Neurosurg · 2011Case Reports
- A standardised method for use of the Leksell GammaPlan Inverse Planning module for metastases.
Fallows P, Wright G, Bownes P · J Radiosurg SBRT · 2019
- Leksell GammaPlan version 10.0 preview: performance of the new inverse treatment planning algorithm applied to Gamma Knife surgery for pituitary adenoma.
Schlesinger DJ, Sayer FT, Yen CP, et al. · J Neurosurg · 2010
- Dosimetric effects of Onyx embolization on Gamma Knife arteriovenous malformation dose distributions.
Schlesinger DJ, Nordström H, Lundin A, et al. · J Neurosurg · 2016Research Support, Non-U.S. Gov't
- Usefulness of Leksell GammaPlan for preoperative planning of brain tumor resection: delineation of the cranial nerves and fusion of the neuroimaging data, including diffusion tensor imaging.
Tamura M, Konishi Y, Tamura N, et al. · Acta Neurochir Suppl · 2013Research Support, Non-U.S. Gov't
- Significance of Dosimetric Parameters in Patients Undergoing Gamma Knife Radiosurgery for Vestibular Schwannoma.
Jayaprakash S, Pendse AM, Deshpande S · J Med Phys · 2022
- Image registration accuracy of GammaPlan: a phantom study.
Watanabe Y, Han E · J Neurosurg · 2008
- Use of GammaPlan convolution algorithm for dose calculation on CT and cone-beam CT images.
Ramachandran P, Perrett B, Dancewicz O, et al. · Radiat Oncol J · 2021
- Determination of volume averaging correction factors using an elliptical absorbed dose model for Gamma Knife Perfexion.
egedin N, Hr¡ak H, Babik SD, et al. · J Appl Clin Med Phys · 2023
Other devices of this type
Also filed under product code IWB.
- Leksell Gamma Knife Perfexion, Leksell Gamma Knife IconElekta Instrument AB · 510(k) 2018
- Leksell Gamma Knife® (Elekta Esprit)Elekta Solutions AB · 510(k) 2025
- GammaPodXcision Medical Systems, LLC · 510(k) 2018
- Leksell GammaPlanElekta Instrument AB · 510(k) 2018
- TaiChiCOur United Corporation · 510(k) 2021
- Akesis Galaxy RTiAkesis, Inc. · 510(k) 2021
- Akesis Galaxy RTxAkesis, Inc. · 510(k) 2020
- Akesis GalaxyAkesis, Inc. · 510(k) 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.